|
US5399363A
(en)
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
NZ268326A
(en)
|
1993-07-19 |
1997-12-19 |
Angiogenesis Tech Inc |
Stent with a coating comprising an anti-angiogenic compound, such as taxol, and a polymeric carrier
|
|
US5994341A
(en)
|
1993-07-19 |
1999-11-30 |
Angiogenesis Technologies, Inc. |
Anti-angiogenic Compositions and methods for the treatment of arthritis
|
|
US5833891A
(en)
|
1996-10-09 |
1998-11-10 |
The University Of Kansas |
Methods for a particle precipitation and coating using near-critical and supercritical antisolvents
|
|
US5874029A
(en)
|
1996-10-09 |
1999-02-23 |
The University Of Kansas |
Methods for particle micronization and nanonization by recrystallization from organic solutions sprayed into a compressed antisolvent
|
|
AU737078C
(en)
|
1996-05-24 |
2002-05-02 |
Angiotech Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing diseases of body passageways
|
|
CA2189916C
(en)
|
1996-11-08 |
2001-01-16 |
Parkash S. Gill |
A new regime for paclitaxel in kaposi's sarcoma patients
|
|
US6495579B1
(en)
*
|
1996-12-02 |
2002-12-17 |
Angiotech Pharmaceuticals, Inc. |
Method for treating multiple sclerosis
|
|
US6515016B2
(en)
|
1996-12-02 |
2003-02-04 |
Angiotech Pharmaceuticals, Inc. |
Composition and methods of paclitaxel for treating psoriasis
|
|
CN100462066C
(zh)
|
1997-06-27 |
2009-02-18 |
美国生物科学有限公司 |
药剂的新制剂及其制备和应用方法
|
|
US6004573A
(en)
|
1997-10-03 |
1999-12-21 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
|
US6117949A
(en)
|
1998-10-01 |
2000-09-12 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
|
IL131217A0
(en)
|
1998-03-10 |
2001-01-28 |
Napro Biotherapeutics Inc |
Novel methods and compositions for delivery of taxanes
|
|
US8293277B2
(en)
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
|
US6113795A
(en)
|
1998-11-17 |
2000-09-05 |
The University Of Kansas |
Process and apparatus for size selective separation of micro- and nano-particles
|
|
IN191203B
(enExample)
|
1999-02-17 |
2003-10-04 |
Amarnath Prof Maitra |
|
|
US6365191B1
(en)
|
1999-02-17 |
2002-04-02 |
Dabur Research Foundation |
Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof
|
|
US6406722B1
(en)
|
1999-02-18 |
2002-06-18 |
Robert G. Gallaher |
Method of treating viral infections and lesions with taxane compounds
|
|
US7217735B1
(en)
|
1999-04-09 |
2007-05-15 |
Au Jessie L-S |
Methods and compositions for enhancing delivery of therapeutic agents to tissues
|
|
ATE312601T1
(de)
|
1999-05-27 |
2005-12-15 |
Acusphere Inc |
Poröse arzneistoffmatrizen und deren herstellungsverfahren
|
|
US6610317B2
(en)
|
1999-05-27 |
2003-08-26 |
Acusphere, Inc. |
Porous paclitaxel matrices and methods of manufacture thereof
|
|
US6892091B1
(en)
|
2000-02-18 |
2005-05-10 |
Biosense, Inc. |
Catheter, method and apparatus for generating an electrical map of a chamber of the heart
|
|
EP1301500B1
(en)
|
2000-06-22 |
2007-11-21 |
Nitromed, Inc. |
Nitrosated and nitrosylated taxanes, compositions and methods of use
|
|
US20040022862A1
(en)
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
|
US8178123B2
(en)
|
2001-08-29 |
2012-05-15 |
Femina Pharma Incorporated |
Method for augmentation of intraepithelial and systemic exposure of therapeutic agents having substrate activity for cytochrome P450 enzymes and membrane efflux systems following vaginal and oral cavity administration
|
|
AU2002329842B2
(en)
|
2001-08-29 |
2006-09-14 |
Umd, Inc. |
Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy
|
|
WO2003032906A2
(en)
|
2001-10-15 |
2003-04-24 |
Crititech, Inc. |
Delivery of poorly soluble drugs
|
|
US20080220075A1
(en)
|
2002-03-20 |
2008-09-11 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
|
DE60309300T3
(de)
|
2002-03-20 |
2011-02-24 |
Elan Pharma International Ltd. |
Nanopartikelzusammensetzungen von angiogeneseinhibitoren
|
|
KR100533458B1
(ko)
|
2002-07-20 |
2005-12-07 |
대화제약 주식회사 |
파클리탁셀의 가용화용 조성물 및 그의 제조 방법
|
|
EP1569620A4
(en)
|
2002-10-30 |
2006-03-22 |
Spherics Inc |
NANOPARTICULAR BIOACTIVE AGENTS
|
|
DK1585548T3
(en)
|
2002-12-09 |
2018-09-03 |
Abraxis Bioscience Llc |
COMPOSITIONS AND PROCEDURES FOR THE DELIVERY OF PHARMACOLOGICAL AGENTS
|
|
ZA200507752B
(en)
|
2003-03-28 |
2007-01-31 |
Threshold Pharmaceuticals Inc |
Compositions and methods for treating cancer
|
|
FR2856301B1
(fr)
|
2003-06-23 |
2007-08-03 |
Galderma Res & Dev |
Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
|
|
US9149440B2
(en)
|
2003-09-02 |
2015-10-06 |
University Of South Florida |
Nanoparticles for drug-delivery
|
|
PT2286794T
(pt)
|
2003-10-15 |
2016-07-13 |
Syncore Biotechnology Co Ltd |
Uso de lipossomas catiónicos contendo placlitaxel
|
|
ES2366646T3
(es)
|
2003-11-05 |
2011-10-24 |
Elan Pharma International Limited |
Composiciones en forma de nanopartículas que tienen un péptido como estabilizante superficial.
|
|
FR2862540B1
(fr)
|
2003-11-21 |
2007-03-30 |
Galderma Res & Dev |
Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
|
|
FR2871695B1
(fr)
|
2004-06-17 |
2008-07-04 |
Galderma Sa |
Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises
|
|
FR2871697B1
(fr)
|
2004-06-17 |
2007-06-29 |
Galderma Sa |
Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
|
|
US7361683B2
(en)
|
2004-11-24 |
2008-04-22 |
Yung Shin Pharm. Ind., Co., Ltd |
Paclitaxel aqueous injection solution and methods for preparing the same
|
|
US8062658B2
(en)
|
2004-12-14 |
2011-11-22 |
Poly-Med, Inc. |
Multicomponent bioactive intravaginal ring
|
|
BRPI0608173A2
(pt)
|
2005-02-24 |
2010-11-09 |
Elan Pharma Int Ltd |
composição, uso da mesma, e, método de produzir uma composição de docetaxel nanoparticulada ou análogo do mesmo
|
|
CN101151028A
(zh)
*
|
2005-03-03 |
2008-03-26 |
Isw集团公司 |
局部用凝胶组合物
|
|
GB0506139D0
(en)
|
2005-03-24 |
2005-05-04 |
Transphase Ltd |
A transdermal topical composition and its uses
|
|
ES2363247T3
(es)
|
2005-04-27 |
2011-07-28 |
Leiden University Medical Center |
Tratamiento para neoplasias intraepiteliales anogenitales inducidas por vph.
|
|
US20090304803A1
(en)
|
2005-06-06 |
2009-12-10 |
The General Hospital Corporation |
Compositions and methods relating to target-specific photodynamic therapy
|
|
US8034765B2
(en)
|
2005-08-31 |
2011-10-11 |
Abraxis Bioscience, Llc |
Compositions and methods for preparation of poorly water soluble drugs with increased stability
|
|
WO2007070850A2
(en)
|
2005-12-14 |
2007-06-21 |
Organogenesis, Inc. |
Skin care compositions and treatments
|
|
US8906392B2
(en)
|
2005-12-16 |
2014-12-09 |
University Of Kansas |
Nanocluster compositions and methods
|
|
US8343962B2
(en)
|
2006-03-06 |
2013-01-01 |
Nuvo Research Inc. |
Topical formulation
|
|
WO2008070279A2
(en)
|
2006-10-11 |
2008-06-12 |
Crititech, Inc. |
Method for precipitation of small medicament particles into use containers
|
|
US8414909B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
|
CA2611803C
(en)
|
2006-11-22 |
2013-03-19 |
Bj Services Company |
Well treatment fluid containing viscoelastic surfactant and viscosification activator
|
|
JP5933893B2
(ja)
|
2006-12-14 |
2016-06-15 |
アブラクシス バイオサイエンス, エルエルシー |
ホルモン受容体状態に基づいてタキサンを含むナノ粒子用いる乳癌治療法
|
|
TWI405590B
(zh)
|
2007-04-06 |
2013-08-21 |
Activus Pharma Co Ltd |
微粉碎化有機化合物粒子之製法
|
|
AU2008260447B2
(en)
|
2007-06-01 |
2013-10-10 |
Abraxis Bioscience, Llc |
Methods and compositions for treating recurrent cancer
|
|
ITMI20071267A1
(it)
|
2007-06-22 |
2008-12-23 |
Fidia Farmaceutici |
Uso di coniugati dell'acido ialuronico nel trattamento locale di malattie cutanee iperproliferative
|
|
HU227970B1
(en)
|
2007-07-10 |
2012-07-30 |
Egis Gyogyszergyar Nyrt |
Pharmaceutical compositions containing silicones of high volatility
|
|
GB0716591D0
(en)
*
|
2007-08-24 |
2007-10-03 |
Vereniging Het Nl Kanker I |
Composition
|
|
CN101129338A
(zh)
|
2007-08-27 |
2008-02-27 |
四川大学 |
超临界流体新技术微细化抗癌药物紫杉醇
|
|
PL2200588T3
(pl)
|
2007-09-25 |
2019-09-30 |
Solubest Ltd. |
Kompozycje zawierające lipofilowe związki aktywne i sposób ich wytwarzania
|
|
KR101563658B1
(ko)
|
2007-11-28 |
2015-10-27 |
셀라토 파마슈티칼즈, 인코포레이티드 |
개선된 탁산 전달 시스템
|
|
WO2009090495A2
(en)
|
2007-12-07 |
2009-07-23 |
Foamix Ltd. |
Oil and liquid silicone foamable carriers and formulations
|
|
US8865194B1
(en)
|
2007-12-20 |
2014-10-21 |
Theraplex Company, LLC |
Reducing tackiness and greasiness of petrolatum-like materials
|
|
US20090175810A1
(en)
|
2008-01-03 |
2009-07-09 |
Gareth Winckle |
Compositions and methods for treating diseases of the nail
|
|
US8952075B2
(en)
|
2008-05-22 |
2015-02-10 |
Poly-Med, Inc. |
Bioactive polymeric liquid formulations of absorbable, segmented aliphatic polyurethane compositions
|
|
WO2009153774A2
(en)
|
2008-06-17 |
2009-12-23 |
Rosetta Genomics Ltd. |
Compositions and methods for prognosis of ovarian cancer
|
|
KR20160130519A
(ko)
|
2008-06-26 |
2016-11-11 |
안테리오스, 인코퍼레이티드 |
경피 운반
|
|
ES2958410T3
(es)
|
2009-08-21 |
2024-02-08 |
Novan Inc |
Geles tópicos
|
|
WO2011039637A2
(en)
|
2009-10-02 |
2011-04-07 |
Foamix Ltd. |
Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
|
|
GB2474930B
(en)
*
|
2009-10-02 |
2012-07-04 |
Foamix Ltd |
Topical tetracycline compositions
|
|
BR112012008772A2
(pt)
|
2009-10-13 |
2017-06-20 |
Rexahn Pharmaceuticals Inc |
sistemas poliméricos para a liberação de agentes anti-câncer
|
|
CN101829061A
(zh)
|
2010-05-14 |
2010-09-15 |
无锡纳生生物科技有限公司 |
一种紫杉醇纳米颗粒组合物及其制备方法
|
|
CN101843582B
(zh)
|
2010-05-18 |
2011-12-21 |
南京工业大学 |
紫杉醇纳米混悬剂及其制备方法
|
|
WO2011151418A2
(en)
|
2010-06-02 |
2011-12-08 |
Abbott Gmbh & Co. Kg |
Nanosusupension formulation comprising a polydimethylsiloxane hydrophobic phase
|
|
US8039494B1
(en)
|
2010-07-08 |
2011-10-18 |
Dow Pharmaceutical Sciences, Inc. |
Compositions and methods for treating diseases of the nail
|
|
US20130211384A1
(en)
|
2010-07-28 |
2013-08-15 |
Fondazione Irccs Istituto Nazionale Dei Tumori |
Therapeutic agent, composition including said agent, implantable device and process for the treatment of cervical cancer and/or for the prevention of the formation of neoplasms in correspondence of the cervix in a human female genital system
|
|
US20130267490A1
(en)
|
2010-08-02 |
2013-10-10 |
Ranbaxy Laboratories Limited |
Topical pharmaceutical composition comprising nanonized silver sulfadiazine and chlorhexidine gluconate
|
|
US8563535B2
(en)
|
2011-03-29 |
2013-10-22 |
Kamal Mehta |
Combination composition comprising benzoyl peroxide and adapalene
|
|
WO2012130314A1
(en)
|
2011-03-31 |
2012-10-04 |
Elara Pharmaceuticals Gmbh |
Composition comprising docetaxel
|
|
KR20140024292A
(ko)
|
2011-04-01 |
2014-02-28 |
유니버시티 오브 플로리다 리서치 파운데이션, 인크. |
치료제의 국소 전달용 감열성, 점막부착성 또는 표피부착성, 및 침투강화성 제제
|
|
US20140073615A1
(en)
|
2011-05-02 |
2014-03-13 |
Lipidor Ab |
Treatment of Psoriasis
|
|
WO2013002636A1
(en)
|
2011-06-27 |
2013-01-03 |
Cristal Delivery B.V. |
Controlled release system
|
|
US20130337070A1
(en)
*
|
2012-05-25 |
2013-12-19 |
University Of Central Florida Research Foundation Inc. |
Coated Nanoparticle Therapy for Skin Cancer
|
|
US9018246B2
(en)
|
2012-09-05 |
2015-04-28 |
Lp Pharmaceutical (Xiamen) Co., Ltd. |
Transmucosal administration of taxanes
|
|
US9149455B2
(en)
|
2012-11-09 |
2015-10-06 |
Abraxis Bioscience, Llc |
Methods of treating melanoma
|
|
JP2014114249A
(ja)
|
2012-12-11 |
2014-06-26 |
Kanae Technos:Kk |
基剤、及び皮膚外用剤
|
|
GB2511115A
(en)
*
|
2013-02-25 |
2014-08-27 |
Linde Ag |
An end port regenerative furnace
|
|
US8778181B1
(en)
|
2013-03-14 |
2014-07-15 |
Crititech, Inc. |
Equipment assembly for and method of processing particles
|
|
EP2978420A4
(en)
|
2013-03-28 |
2016-12-21 |
Bbs Nanotechnology Ltd |
STABLE NANO COMPOSITION WITH DOXORUBICIN, PROCESS FOR THE PREPARATION THEREOF, THE USE THEREOF AND PHARMACEUTICAL COMPOSITIONS THEREWITH
|
|
BR112015032758A2
(pt)
|
2013-06-28 |
2017-07-25 |
Bind Therapeutics Inc |
nanopartículas poliméricas de docetaxel para o tratamento de câncer
|
|
TWI601542B
(zh)
|
2014-04-18 |
2017-10-11 |
林信湧 |
一種用於治療肺癌之吸入式醫藥組成物及其備製方法
|
|
WO2015187194A1
(en)
|
2014-06-01 |
2015-12-10 |
Crititech, Inc. |
Use of paclitaxel particles
|
|
WO2016071365A1
(en)
|
2014-11-03 |
2016-05-12 |
Spherium Biomed, S.L. |
Topical pharmaceutical compositions of paclitaxel
|
|
CN105280869B
(zh)
|
2015-01-07 |
2018-07-31 |
保定钰鑫电气科技有限公司 |
一种组合式蓄电池端子连接片
|
|
CA3026454C
(en)
|
2015-06-04 |
2023-07-04 |
Crititech, Inc. |
Collection device and methods for use
|
|
CN114588270B
(zh)
|
2015-09-16 |
2024-08-06 |
Dfb索里亚有限责任公司 |
包含紫杉烷类纳米颗粒的组合物及其用途
|
|
CN105380869A
(zh)
*
|
2015-12-28 |
2016-03-09 |
深圳中农科工创业资产管理有限公司 |
一种纳米红豆杉护肤品及其用途
|
|
BR112018069628A2
(pt)
|
2016-04-04 |
2019-02-12 |
Crititech, Inc. |
métodos para tratamento de tumor sólido
|
|
EP3595633B1
(en)
*
|
2017-03-15 |
2023-07-05 |
DFB Soria, LLC |
Topical therapy for the treatment of skin malignancies using nanoparticles of taxanes
|